Pentwater Capital Management LP Intra Cellular Therapies, Inc. Transaction History
Pentwater Capital Management LP
- $11.7 Billion
- Q1 2025
A detailed history of Pentwater Capital Management LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pentwater Capital Management LP holds 5,190,000 shares of ITCI stock, worth $684 Million. This represents 5.83% of its overall portfolio holdings.
Number of Shares
5,190,000Holding current value
$684 Million% of portfolio
5.83%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
443Shares Held
90.4MCall Options Held
2.24MPut Options Held
1.86M-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.49MShares$460 Million16.46% of portfolio
-
Ubs Oconnor LLC Chicago, IL3.09MShares$408 Million28.36% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.06MShares$403 Million2.32% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...